Health-care use drives the economic burden of blood disorders in Europe

Affiliations

¹ Department Pharmaceutical and Pharmacological Sciences, University of Leuven, 3000 Leuven, Belgium. Electronic address: Kim.Pauwels@kuleuven.be.
² Department of Oncology, Laboratory for Experimental Hematology, University of Leuven, Leuven, Belgium; Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
³ Department Pharmaceutical and Pharmacological Sciences, University of Leuven, 3000 Leuven, Belgium.

Comment

Kim Pauwels et al. Lancet Haematol. 2016 Aug.

. 2016 Aug;3(8):e355-6.

doi: 10.1016/S2352-3026(16)30077-1. Epub 2016 Jul 22.

¹ Department Pharmaceutical and Pharmacological Sciences, University of Leuven, 3000 Leuven, Belgium. Electronic address: Kim.Pauwels@kuleuven.be.
² Department of Oncology, Laboratory for Experimental Hematology, University of Leuven, Leuven, Belgium; Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
³ Department Pharmaceutical and Pharmacological Sciences, University of Leuven, 3000 Leuven, Belgium.

No abstract available

Comment in

Costs of haematological disease high and rising.
Green T, Bron D, Chomienne C, de Wit TD, de Haas F, Engert A, Hagenbeek A, Jäger U, MacIntyre E, Muckenthaler MU, Smand C, Sonneveld P. Green T, et al. Lancet Haematol. 2016 Aug;3(8):e353-4. doi: 10.1016/S2352-3026(16)30074-6. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476782 No abstract available.

Costs of haematological disease high and rising.
Green T, Bron D, Chomienne C, de Wit TD, de Haas F, Engert A, Hagenbeek A, Jäger U, MacIntyre E, Muckenthaler MU, Smand C, Sonneveld P. Green T, et al. Lancet Haematol. 2016 Aug;3(8):e353-4. doi: 10.1016/S2352-3026(16)30074-6. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476782 No abstract available.
Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R, Leal J, Sullivan R, Luengo-Fernandez R. Burns R, et al. Lancet Haematol. 2016 Aug;3(8):e362-70. doi: 10.1016/S2352-3026(16)30062-X. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476787
Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
Luengo-Fernandez R, Burns R, Leal J. Luengo-Fernandez R, et al. Lancet Haematol. 2016 Aug;3(8):e371-8. doi: 10.1016/S2352-3026(16)30061-8. Epub 2016 Jul 22. Lancet Haematol. 2016. PMID: 27476788